1. Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial. Issue 1 (January 2020) Authors: Beelen, Dietrich Wilhelm; Trenschel, Rudolf; Stelljes, Matthias; Groth, Christoph; Masszi, Tamás; Reményi, Péter; Wagner-Drouet, Eva-Maria; Hauptrock, Beate; Dreger, Peter; Luft, Thomas; Bethge, Wolfgang; Vogel, Wichard; Ciceri, Fabio; Peccatori, Jacopo; Stölzel, Friedrich; Schetelig, Johannes; J... Journal: Lancet Issue: Volume 7:Issue 1(2020) Page Start: e28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗